Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Biotie Therapies Corp -Company Report'
Title Publication Date Price Relevance
Biotie Therapies Corp.-Therapeutic Competitors Report Mar 2011 £220 100%
Biotie Therapies Corp.-Deals & Alliances Report Mar 2011 £380 99%
Alcohol Addiction - Pipeline Review
H2 2011
 Aug 2011 £315 74%
Addiction – Pipeline Review
H2 2011
 Dec 2011 £315 73%
Panic Disorders Global Clinical Trials Review
Q1, 2011
 Mar 2011 £630 72%
Alzheimer's Disease - Pipeline Review
H2 2011
 Sep 2011 £315 69%
Schizophrenia - Pipeline Review
H2 2011
 Sep 2011 £315 69%
Depression - Pipeline Review
H2 2011
 Aug 2011 £315 69%
World Market for Addiction Disorders, 2009-2016
The Future Therapies for Substance Dependence and Impulse Control
 Oct 2009 £1,495 67%
Bipolar Disorder (Manic Depression) - Pipeline Review
H2 2011
 Sep 2011 £315 65%
Alcoholism - Pipeline Review
Q2 2011
 Apr 2011 £315 65%
Depression - Pipeline Review
Q2 2011
 Apr 2011 £315 65%
Post-Traumatic Stress Disorder (Ptsd) - Pipeline Review
H2 2011
 Aug 2011 £315 64%
Rhinitis - Pipeline Review
H2 2011
 Sep 2011 £315 63%
Atopic Dermatitis (Eczema) - Pipeline Review
H2 2011
 Sep 2011 £315 61%
Rheumatoid Arthritis Therapeutics Feb 2010 £2,500 60%
Biotechnology (Pharmaceuticals) Report - Global
Business Performance Analysis
 Aug 2011 £950 58%
Parkinson's Disease - Pipeline Review
H1 2012
 Jan 2012 £325 57%
Psoriasis - Pipeline Review
H2 2011
 Sep 2011 £315 55%
Rheumatoid Arthritis - Pipeline Review
H2 2011
 Sep 2011 £315 50%
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review
H2 2011
 Sep 2011 £315 49%
Asthma - Pipeline Review
H2 2011
 Sep 2011 £315 47%